<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Endocrinol Metab</journal-id><journal-id journal-id-type="iso-abbrev">J. Clin. Endocrinol. Metab</journal-id><journal-id journal-id-type="pmc-domain-id">561</journal-id><journal-id journal-id-type="pmc-domain">jcem</journal-id><journal-id journal-id-type="publisher-id">jceme</journal-id><journal-title-group><journal-title>The Journal of Clinical Endocrinology and Metabolism</journal-title></journal-title-group><issn pub-type="ppub">0021-972X</issn><issn pub-type="epub">1945-7197</issn><publisher><publisher-name>The Endocrine Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC4880116</article-id><article-id pub-id-type="pmcid-ver">PMC4880116.1</article-id><article-id pub-id-type="pmcaid">4880116</article-id><article-id pub-id-type="pmcaiid">4880116</article-id><article-id pub-id-type="pmid">26760044</article-id><article-id pub-id-type="doi">10.1210/jc.2015-1710</article-id><article-id pub-id-type="publisher-id">15-1710</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Special Features</subject></subj-group><series-title>Clinical Practice Guideline</series-title></article-categories><title-group><article-title>Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Bornstein</surname><given-names initials="SR">Stefan R.</given-names></name><role>chair</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Allolio</surname><given-names initials="B">Bruno</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Arlt</surname><given-names initials="W">Wiebke</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Barthel</surname><given-names initials="A">Andreas</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Don-Wauchope</surname><given-names initials="A">Andrew</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hammer</surname><given-names initials="GD">Gary D.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Husebye</surname><given-names initials="ES">Eystein S.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Merke</surname><given-names initials="DP">Deborah P.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Murad</surname><given-names initials="MH">M. Hassan</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stratakis</surname><given-names initials="CA">Constantine A.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Torpy</surname><given-names initials="DJ">David J.</given-names></name></contrib><aff>Medizinische Klinik und Poliklinik III (S.R.B., A.B.), Universitätsklinikum Dresden, 01307 Dresden, Germany; Department of Endocrinology and Diabetes (S.R.B.), King's College London, London WC2R 2LS, United Kingdom; Department of Internal Medicine I (B.A.), Endocrine and Diabetes Unit, University Hospital Würzburg, 97080 Würzburg, Germany; Comprehensive Heart Failure Center (B.A.), University of Würzburg, 97080 Würzburg, Germany; Centre for Endocrinology, Diabetes, and Metabolism (W.A.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Endokrinologikum Ruhr (A.B.), 44866 Bochum, Germany; Department of Pathology and Molecular Medicine (A.D.-W.), McMaster University, Hamilton, ON L8S 4L8, Canada; Hamilton Regional Laboratory Medicine Program (A.D.-W.), Hamilton, ON L8N 4A6, Canada; Department of Internal Medicine (G.D.H.), Division of Metabolism, Endocrinology, and Diabetes, and Cancer Center, University of Michigan, Ann Arbor, Michigan 48109; Department of Clinical Science, University of Bergen, and Department of Medicine, Haukeland University Hospital (E.S.H.), 5021 Bergen, Norway; National Institutes of Health Clinical Center (D.P.M.), Bethesda, Maryland 20814; Mayo Clinic, Division of Preventive Medicine (M.H.M.), Rochester, Minnesota 55905; <italic toggle="yes">Eunice Kennedy Shriver</italic> National Institute of Child Health and Human Development (C.A.S.), National Institutes of Health, Bethesda, Maryland 20892; and Endocrine and Metabolic Unit (D.J.T.), Royal Adelaide Hospital, University of Adelaide, Adelaide SA 5000, Australia</aff></contrib-group><author-notes><corresp>Address all correspondence and requests for reprints to: The Endocrine Society, 2055 L Street NW, Suite 600, Washington, DC 20036. E-mail: <email>govt-prof@endocrine.org</email>; Phone: 202-971-3636. Send commercial reprint requests for orders over 100 to: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.endocrine.org/corporaterelations/commercial-reprints">https://www.endocrine.org/corporaterelations/commercial-reprints</ext-link>. Send commercial reprint requests for orders under 100 to: Society Services. E-mail: <email>societyservices@endocrine.org</email>; Phone: 202-971-3636; Fax: 202-736-9705.</corresp></author-notes><pub-date pub-type="ppub"><month>2</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>13</day><month>12</month><year>2015</year></pub-date><volume>101</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">270023</issue-id><fpage>364</fpage><lpage>389</lpage><history><date date-type="received"><day>18</day><month>3</month><year>2015</year></date><date date-type="accepted"><day>2</day><month>12</month><year>2015</year></date></history><pub-history><event event-type="pmc-release"><date><day>13</day><month>12</month><year>2015</year></date></event><event event-type="pmc-live"><date><day>31</day><month>05</month><year>2016</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2018-02-03 00:19:43.613"><day>03</day><month>02</month><year>2018</year></date></event></pub-history><permissions><copyright-statement>Copyright © 2016 by the Endocrine Society</copyright-statement><copyright-year>2016</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="zeg364.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="pdf" xlink:href="zeg00216000364.pdf"/><abstract><sec><title>Objective:</title><p>This clinical practice guideline addresses the diagnosis and treatment of primary adrenal insufficiency.</p></sec><sec><title>Participants:</title><p>The Task Force included a chair, selected by The Clinical Guidelines Subcommittee of the Endocrine Society, eight additional clinicians experienced with the disease, a methodologist, and a medical writer. The co-sponsoring associations (European Society of Endocrinology and the American Association for Clinical Chemistry) had participating members. The Task Force received no corporate funding or remuneration in connection with this review.</p></sec><sec><title>Evidence:</title><p>This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to determine the strength of recommendations and the quality of evidence.</p></sec><sec><title>Consensus Process:</title><p>The evidence used to formulate recommendations was derived from two commissioned systematic reviews as well as other published systematic reviews and studies identified by the Task Force. The guideline was reviewed and approved sequentially by the Endocrine Society's Clinical Guidelines Subcommittee and Clinical Affairs Core Committee, members responding to a web posting, and the Endocrine Society Council. At each stage, the Task Force incorporated changes in response to written comments.</p></sec><sec><title>Conclusions:</title><p>We recommend diagnostic tests for the exclusion of primary adrenal insufficiency in all patients with indicative clinical symptoms or signs. In particular, we suggest a low diagnostic (and therapeutic) threshold in acutely ill patients, as well as in patients with predisposing factors. This is also recommended for pregnant women with unexplained persistent nausea, fatigue, and hypotension. We recommend a short corticotropin test (250 μg) as the “gold standard” diagnostic tool to establish the diagnosis. If a short corticotropin test is not possible in the first instance, we recommend an initial screening procedure comprising the measurement of morning plasma ACTH and cortisol levels. Diagnosis of the underlying cause should include a validated assay of autoantibodies against 21-hydroxylase. In autoantibody-negative individuals, other causes should be sought. We recommend once-daily fludrocortisone (median, 0.1 mg) and hydrocortisone (15–25 mg/d) or cortisone acetate replacement (20–35 mg/d) applied in two to three daily doses in adults. In children, hydrocortisone (∼8 mg/m<sup>2</sup>/d) is recommended. Patients should be educated about stress dosing and equipped with a steroid card and glucocorticoid preparation for parenteral emergency administration. Follow-up should aim at monitoring appropriate dosing of corticosteroids and associated autoimmune diseases, particularly autoimmune thyroid disease.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>